Skip to main content
Livermore
Livermore
ZHEN

Johnson & Johnson

SEC CIK
0000200406
Latest filing
Aug 6, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q3 2021
Holdings of ARWR by Johnson & Johnson, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−247,598−100.0%Sold outHolders
Q3 2025247,598$8.54M1.7%00.0%UnchangedHolders
Q2 2025247,598$3.98M1.2%00.0%UnchangedHolders
Q1 2025247,598$3.15M0.9%00.0%UnchangedHolders
Q4 2024247,598$4.65M1.2%00.0%UnchangedHolders
Q3 2024247,598$4.80M1.1%00.0%UnchangedHolders
Q2 2024247,598$6.44M1.6%00.0%UnchangedHolders
Q1 2024247,598$7.08M0.2%00.0%UnchangedHolders
Q4 2023247,598$7.58M0.2%00.0%UnchangedHolders
Q3 2023247,598$6.65M2.5%00.0%UnchangedHolders
Q2 2023247,598$8.83M2.7%00.0%UnchangedHolders
Q1 2023247,598$6.29M2.0%00.0%UnchangedHolders
Q4 2022247,598$10.0M2.9%00.0%UnchangedHolders
Q3 2022247,598$8.18M2.4%−1,013,271−80.4%ReducedHolders
Q2 20221,260,869$44.4M11.3%00.0%UnchangedHolders
Q1 20221,260,869$58.0M11.0%−2,000,000−61.3%ReducedHolders
Q4 20213,260,869$216.2M24.6%00.0%UnchangedHolders
Q3 20213,260,869$203.6M17.9%–No prior filingHolders